| (Values in U.S. Thousands) | Sep, 2023 | Jun, 2023 | Mar, 2023 | Sep, 2022 | Jun, 2022 |
| Sales | 333,172 | 338,580 | 336,496 | 345,987 | 339,728 |
| Sales Growth | -1.60% | +0.62% | -2.74% | +1.84% | +1.79% |
| Net Income | -92,347 | -71,242 | -54,380 | -270,302 | -51,475 |
| Net Income Growth | -29.62% | -31.01% | +79.88% | -425.11% | -135.16% |
Curaleaf Holdings Inc (CURA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
Fiscal Year End Date: 12/31